According to West Pharmaceutical's latest financial reports the company's current earnings are S$2.89 Billion. In 2024 the company made an earning of S$0.75 Billion a decrease over its 2023 earnings that were of S$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | S$0.75 B | 0.58% |
2024 | S$0.75 B | -16.12% |
2023 | S$0.89 B | 2.66% |
2022 | S$0.87 B | -9.21% |
2021 | S$0.96 B | 86.62% |
2020 | S$0.51 B | 37.53% |
2019 | S$0.37 B | 21.23% |
2018 | S$0.30 B | 8.23% |
2017 | S$0.28 B | 17.18% |
2016 | S$0.24 B | 63.48% |
2015 | S$0.14 B | -31.3% |
2014 | S$0.21 B | 14.89% |
2013 | S$0.18 B | 35.58% |
2012 | S$0.13 B | 16.92% |
2011 | S$0.11 B | 341.9% |
2010 | S$27.02 M | -74.73% |
2009 | S$0.10 B | -24.18% |
2008 | S$0.14 B | 26.85% |
2007 | S$0.11 B | 2.25% |
2006 | S$0.10 B | 87.36% |
2005 | S$58.03 M | -12.77% |
2004 | S$66.52 M | 12.88% |
2003 | S$58.93 M | 164.74% |
2002 | S$22.26 M | -35.21% |
2001 | S$34.35 M | 761.29% |
2000 | S$3.98 M | -94.57% |
1999 | S$73.47 M | 104.66% |
1998 | S$35.9 M | -51.73% |
1997 | S$74.37 M | 112.5% |
1996 | S$35 M | -36.15% |
1995 | S$54.81 M | 4.67% |
1994 | S$52.37 M | 10.6% |
1993 | S$47.35 M | 8.24% |
1992 | S$43.75 M | -971.79% |
1991 | -S$5.02 Million | -136.11% |
1990 | S$13.89 M | -70.08% |
1989 | S$46.45 M | 18.75% |
1988 | S$39.11 M | 1.67% |
1987 | S$38.47 M | -2.92% |
1986 | S$39.63 M | 30.51% |
1985 | S$30.36 M | 14.56% |
1984 | S$26.5 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Becton Dickinson BDX | S$2.16 B | 195.99% | ๐บ๐ธ USA |
![]() Antares Pharma ATRS | S$84.77 M | -88.41% | ๐บ๐ธ USA |
![]() ICU Medical
ICUI | S$83.94 M | -88.53% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | S$4.28 B | 486.18% | ๐บ๐ธ USA |
![]() Baxter BAX | -S$0.92 Billion | -225.22% | ๐บ๐ธ USA |
![]() Teleflex TFX | S$0.37 B | -49.06% | ๐บ๐ธ USA |
![]() Medtronic MDT | S$7.69 B | 951.53% | ๐ฎ๐ช Ireland |
![]() Johnson & Johnson JNJ | S$35.26 B | 4,720.26% | ๐บ๐ธ USA |